David Cash

David Cash is the co-founder and Managing Partner of Medvest Capital, a venture firm which has invested in early-stage medical technology which improve patient outcomes and decrease the cost of patient care. He specializes in developing early- stage strategy, scaling commercial activities, achieving clinical distinction, and attracting later stage capital. Mr. Cash currently serves as director at Providence Medical Technology, Osteal Therapeutics and BrightSpec. Additionally, he serves as a board observer at FreeSpria and Mercator Medical Systems. Prior to creating Medvest Capital, Mr. Cash founded a development firm specializing in healthcare facilities and ambulatory surgery centers. Early in his career, he worked as a financial analyst at CIBC World Markets’ Investment Banking Division. David earned an MBA from the Darden School of Business at the University of Virginia where he was awarded the Genovese Fellowship. His Bachelor of Arts was received from Colgate University with honors.